Zeureka and Sumitomo Pharma Collaborate on Molecule Drug Discovery Research Zeureka and Sumitomo Pharma have signed a research agreement to work on low-molecular drug discovery, aiming to innovate new pharmaceutical candidates together.

Zeureka and Sumitomo Pharma Collaborate on Molecule Drug Discovery Research #Japan #Tokyo #Drug_Discovery #Sumitomo_Pharma #Zeureka

ZeuReka and UBE Forge Strategic Partnership in Oncology Drug Discovery ZeuReka and UBE have signed a collaborative research agreement focusing on low-molecule drug discovery for cancer treatment, leveraging advanced computational technologies.

ZeuReka and UBE Forge Strategic Partnership in Oncology Drug Discovery #Japan #oncology #Tokyo #UBE #Zeureka

RealizeEdge Partners Enters Contract with Zeureka to Develop Pioneer Protein Degrading Agents RealizeEdge Partners has signed a contract with Zeureka to develop novel targeted protein degraders and Degrader-Antibody Conjugates, enhancing drug discovery.

RealizeEdge Partners Enters Contract with Zeureka to Develop Pioneer Protein Degrading Agents #Japan #Tokyo #Zeureka #Protein_Degrader #RealizeEdge

Zeureka Teams Up with Funpep to Support AI Drug Discovery of Special Peptides Zeureka, a subsidiary of Mitsui & Co., partners with Funpep to provide AI drug discovery support for special peptides, advancing their research goals.

Zeureka Teams Up with Funpep to Support AI Drug Discovery of Special Peptides #Japan #Osaka #AI_Drug_Discovery #Zeureka #Funpep